| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.031 | 0.6 |